Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Associate Professor Francesca Buffa who has been awarded a five-year €2M grant by the European Research Council (ERC) to develop computer simulations of cancer cell behaviour, to help us personalise cancer treatment and prevent drug resistance.

In many cases we know which parts of cells go wrong when they divide uncontrollably, leading to cancer. Also, we are becoming better and better at developing drugs which correct each individual problem.

However, cancer cells often depend on more than one thing going wrong (often a gene mutation). This series of changes “rewires” the cancer cell circuitry, and each person’s cancer will have its own combination of re-wiring.  This means that each person will need a different drug or combination of drugs to correct this rewiring and cure their disease.

When tumours no longer respond to drug treatment in the clinic, they have often become resistant by gaining more mutations and switching their circuitry. Then it is difficult for us to know which treatment to give.

To help us understand the flexibility in cancer cell circuitry, Francesca (a mathematical biologist) is constructing ‘virtual’ cancer cells inside a computer from what we know about the mutations that affect real cancer cell behaviour. Effectively, she is turning the cancer cell ‘circuits’ into real electrical circuits inside a computer.

These “in-silico“ cancer cells undergo constant improvements using up-to-date information from cancer cell biologists, until hopefully the cancer cells inside the computer will behave just like real living cancer cells.

The virtual cancer cells will enable us to test the effects of different drugs or drug combinations in a computer rather than in real-world clinical trials. This will dramatically increase the speed and reduce the cost of research.

Eventually, a biopsy from each real tumour could be used to generate an equivalent virtual tumour, which would then be used to quickly identify the best therapy for that patient. This means that Francesca’s work represents a potentially important step towards truly personalised cancer medicine.

Similar stories

Researchers develop easy-to-deploy federated learning system that safeguards patient data

The technique, which builds on recent advances in decentralised machine learning, uses inexpensive pre-programmed micro-computers, making it easy to deploy in hospitals and cheap to scale up.

Festive Science Image Competition Winners

Winners of the Medical Research Foundation's second Festive Science Image Competition, run in partnership with the Medical Research Council (MRC), have been announced today.

Robert Watson Awarded ACP McElwain and Presidents Prize

Dr Robert Watson has won one of three McElwain and President's Prizes from the Association of Cancer Physicians for his DPhil work undertaken with Professor Ben Fairfax.

Prof Anna Schuh launches first private specialised haematology clinic and laboratory in sub-Saharan Africa.

SerenOx Africa aims to address diagnostic gaps for common blood disorders through a testing facility for key underserved patient populations in Tanzania. This facility will also aim to provide early cancer detection for high-risk patients.